FIDSX | FSRBX | FIDSX / FSRBX | |
Total Expense Ratio | 0.69 | 0.71 | 97% |
Annual Report Gross Expense Ratio | 0.69 | 0.71 | 97% |
Fund Existence | 44 years | 39 years | - |
Gain YTD | 0.344 | -5.753 | -6% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.05B | 410M | 255% |
Annual Yield % from dividends | 1.42 | 2.30 | 62% |
Returns for 1 year | 19.95 | 17.99 | 111% |
Returns for 3 years | 52.84 | 31.58 | 167% |
Returns for 5 years | 102.65 | 89.85 | 114% |
Returns for 10 years | 80.82 | 19.55 | 413% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 12.20 | -0.07 | -0.57% |
AlphaCentric Life Sciences & Hlthcare A | |||
TNBIX | 19.59 | -0.22 | -1.09% |
1290 SmartBeta Equity I | |||
JMVAX | 15.28 | -0.19 | -1.23% |
Janus Henderson Mid Cap Value I | |||
BFTHX | 58.26 | -0.82 | -1.39% |
Baron Fifth Avenue Growth Retail | |||
PLGJX | 10.04 | -0.16 | -1.57% |
Principal LargeCap Growth I J |